Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnosis and treatment of multiple sclerosis.

Literature DB >> 16513709

Diagnosis and treatment of multiple sclerosis.

T J Murray¹.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 16513709 PMCID： PMC1388131 DOI： 10.1136/bmj.332.7540.525

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

13 in total

1. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.

Authors: D S Goodin; E M Frohman; G P Garmany; J Halper; W H Likosky; F D Lublin; D H Silberberg; W H Stuart; S van den Noort
Journal: Neurology Date: 2002-01-22 Impact factor: 9.910

2. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors: L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal: N Engl J Med Date: 2000-09-28 Impact factor: 91.245

3. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.

Authors: S A Morrow; C A Stoian; J Dmitrovic; S C Chan; L M Metz
Journal: Neurology Date: 2004-09-28 Impact factor: 9.910

Review 4. The neuropsychiatry of multiple sclerosis.

Authors: Anthony Feinstein
Journal: Can J Psychiatry Date: 2004-03 Impact factor: 4.356

5. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria.

Authors: T Fangerau; S Schimrigk; M Haupts; M Kaeder; G Ahle; N Brune; K Klinkenberg; S Kotterba; M Möhring; E Sindern
Journal: Acta Neurol Scand Date: 2004-06 Impact factor: 3.209

6. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors: E M Frohman; D S Goodin; P A Calabresi; J R Corboy; P K Coyle; M Filippi; J A Frank; S L Galetta; R I Grossman; K Hawker; N J Kachuck; M C Levin; J T Phillips; M K Racke; V M Rivera; W H Stuart
Journal: Neurology Date: 2003-09-09 Impact factor: 9.910

Review 7. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors: D S Goodin; B G Arnason; P K Coyle; E M Frohman; D W Paty
Journal: Neurology Date: 2003-11-25 Impact factor: 9.910

8. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.

Authors: Hans-Peter Hartung; Richard Gonsette; Nikolaus König; Hubert Kwiecinski; Andreas Guseo; Sean P Morrissey; Hilmar Krapf; Thomas Zwingers
Journal: Lancet Date: 2002 Dec 21-28 Impact factor: 79.321

9. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

Authors: Sean J Pittock; Robyn L McClelland; William T Mayr; Neal W Jorgensen; Brian G Weinshenker; John Noseworthy; Moses Rodriguez
Journal: Ann Neurol Date: 2004-08 Impact factor: 10.422

10. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422

40 in total

1. Diagnosis and treatment of multiple sclerosis: potential changes in management for clinically isolated episode of optic neuritis.

Authors: Peter D Cackett; James Cameron; Harry Bennett
Journal: BMJ Date: 2006-03-18

2. Diagnosis and treatment of multiple sclerosis: ocular manifestations of multiple sclerosis.

Authors: Mohammad T Masoud
Journal: BMJ Date: 2006-03-18

3. Perceived met and unmet health-care needs in a community population with multiple sclerosis.

Authors: Scott B Patten; Jeanne V A Williams; Dina H Lavorato; David Terriff; Luanne M Metz; Sandy Berzins; Andrew G M Bulloch
Journal: Int J MS Care Date: 2012

4. Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.

Authors: Nancy J Holland; Diana M Schneider; Robert Rapp; Rosalind C Kalb
Journal: Int J MS Care Date: 2011